Q&A

Pediatric Drug Delivery: Challenges And Solutions

Source: Catalent
iStock-842481112-child-medicine-tablet-capsule

Novel oral dosage forms address formulation challenges across age groups.

Recognizing that physiological changes happen from birth through adolescence—leading to differences in pharmacokinetics (PK) and pharmacodynamics (PD)—developing medicines for the pediatric population can be challenging, requiring different formulations, different dosage forms and strengths, or different routes of administration depending on the patient’s age. In this Q&A, Pascale Clement, PhD, Director of Science and Technology, OptiForm Solution Suite and Softgels at Catalent, and Uwe Hanenberg, PhD, Director of Science and Technology, Oral Solids at Catalent, shared more about new technologies for developing and delivering optimal dosage forms that address adherence and acceptability in pediatric populations.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: